InspireMD, Inc. vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| NSPR | SYK | |
|---|---|---|
| Market Cap | $36.53 million | $105.53 billion |
| Revenue (TTM) | $10.84 million | $25.84 billion |
| Net Income (TTM) | $-52,482,000 | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| NSPR | SYK | |
|---|---|---|
| P/E Ratio | — | 28.51 |
| Price / Book | 1.16 | 4.40 |
| Price / Sales | 3.37 | 4.08 |
NSPR leads on 2 of 2 valuation factors.
Profitability
| NSPR | SYK | |
|---|---|---|
| Net Margin | -484.11% | 14.43% |
| Return on Equity | -166.55% | 15.55% |
SYK leads on 2 of 2 profitability factors.
Dividend
| NSPR | SYK | |
|---|---|---|
| Dividend Yield | — | 1.28% |
| Payout Ratio | — | 36.48 |
NSPR and SYK split the dividend factors evenly.
Risk & Sentiment
| NSPR | SYK | |
|---|---|---|
| Short Interest | 3.14% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: NSPR overview, NSPR financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.